BioSpace News Archive

Business

Applied Therapeutics Reports Third Quarter 2019 Financial Results

Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel drug candidates in indications of high unmet medical need, reported financial results for the third quarter ended September 30, 2019.

November 13, 2019
·
10 min read
Business

Kamada Reports Financial Results for Third Quarter and First Nine Months of 2019

Total Revenues for Third Quarter and First Nine Months of 2019 were $33.1 Million and $95.1 Million, Respectively, Compared to $15.0 Million and $66.3 Million in the Respective Periods in 2018.

November 13, 2019
·
17 min read
Business

RedHill Biopharma to Host Third Quarter 2019 Financial Results Conference Call on November 19, 2019

RedHill Biopharma Ltd. announced that it will report its third quarter 2019 financial results and operational highlights on Tuesday, November 19, 2019.

November 13, 2019
·
5 min read
Pharm Country

Antares Pharma to Present at the Jefferies 2019 London Healthcare Conference

Antares Pharma, Inc. announced that Robert F. Apple, President and Chief Executive Officer, will present at the Jefferies 2019 London Healthcare Conference on Wednesday November 20, 2019, at 11:20 am / 6:20 am in London, UK.

November 13, 2019
·
4 min read
Intec Pharma to Participate in Jefferies London Healthcare Conference

Intec Pharma Ltd. announces that Company management will participate in the Jefferies London Healthcare Conference..

November 13, 2019
·
4 min read
Biotech Bay

Protagonist Therapeutics to Present at Two Upcoming Healthcare Investor Conferences

Protagonist Therapeutics, Inc. announced that Dinesh V. Patel, Ph.D., President and Chief Executive Officer, will present at two upcoming healthcare investor conferences in New York..

November 13, 2019
·
1 min read
Business

Evogene Reports Third Quarter 2019 Financial Results

Evogene Ltd., a leading biotechnology company developing novel products for life science markets, announces its financial results for the third quarter, ending September 30, 2019.

November 13, 2019
·
13 min read
Policy

LifeMax Receives Orphan Drug Designation From the European Commission for LM-030 for the Treatment of Netherton Syndrome

LifeMax Laboratories, Inc. announced that the European Commission granted orphan drug designation to LM-030, an investigational therapy licensed from Novartis and ready to enter into a pivotal clinical trial for the treatment of Netherton Syndrome.

November 13, 2019
·
2 min read
Business

Aruna Bio Appoints Dr. Renee Boerner as Vice President of Regulatory Affairs

Aruna Bio, Inc., a leader in the development of neural exosomes for the treatment of neurodegenerative diseases, announced the appointment of Renee Boerner, PhD, as Vice President of Regulatory Affairs.

November 13, 2019
·
2 min read
Genetown

ArQule to Participate in the Jefferies London Healthcare Conference on November 20, 2019

ArQule, Inc. announced that Paolo Pucci, Chief Executive Officer, will participate in the Jefferies London Healthcare Conference on Wednesday, November 20, 2019 in London, UK.

November 13, 2019
·
1 min read